SOX30 and non-small cell lung carcinoma: Survival analysis using Kaplan-Meier and log rank test revealed poorer OS in NSCLC patients characterized with low SOX30 expression as compared to patients with high SOX30 expression (P = 0.014) (Fig. 2A).